Related Experiment Video
Updated: Aug 15, 2025

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Melatonin for Insomnia in Medical Inpatients: A Narrative Review
Christine Salahub1, Peter E Wu2,3, Lisa D Burry4,5,6
1Support, Systems, and Outcomes Department, University Health Network, Toronto, ON M5G 2C4, Canada.
Hospital insomnia is common and can worsen patient outcomes. Melatonin may be a safer alternative to traditional sleep medications for inpatients, especially older adults, with careful consideration of its use.
Area of Science:
- Sleep Medicine
- Pharmacology
- Geriatrics
Background:
- Hospital-acquired insomnia is prevalent, leading to reduced sleep and increased nighttime awakenings.
- Sleep disturbances in hospitalized patients are linked to heightened inflammation, pain, and delirium risk.
- Current insomnia treatments require careful risk-benefit analysis due to potential adverse effects.
Purpose of the Study:
- To review non-pharmacological and pharmacological insomnia treatments for medical inpatients.
- To focus on the role and efficacy of melatonin as a treatment option.
- To evaluate the safety and effectiveness of melatonin compared to other sedative-hypnotics.
Main Methods:
- Narrative review of existing literature on insomnia treatments in hospitalized patients.
- Focused analysis on melatonin's properties, efficacy, and safety profile.
- Comparison of melatonin with benzodiazepines and non-benzodiazepine receptor agonists.
Main Results:
- Traditional sedative-hypnotics carry risks, particularly for patients over 65, including falls and cognitive decline.
- Exogenous melatonin demonstrates a lower likelihood of adverse effects and drug interactions.
- Melatonin shows comparable effectiveness to other sedative-hypnotics.
Conclusions:
- Melatonin may be a suitable option for inpatient insomnia refractory to non-pharmacological methods.
- Further research is warranted to confirm melatonin's effectiveness and safety in hospitalized populations.
- Low-dose melatonin before bedtime could be considered for inpatients experiencing persistent insomnia.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Insomnia
Multiple factors contribute...
Narcolepsy
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

